Sector
PharmaceuticalsOpen
₹19Prev. Close
₹21.68Turnover(Lac.)
₹4.69Day's High
₹19.65Day's Low
₹1952 Week's High
₹28.4952 Week's Low
₹10Book Value
₹14.59Face Value
₹10Mkt Cap (₹ Cr.)
9.47P/E
195.7EPS
0.1Divi. Yield
0Y/e 31 Mar( In .Cr) | Mar-2023 | Mar-2022 | Mar-2021 | Mar-2020 |
---|---|---|---|---|
Equity Capital | 4.06 | 4.06 | 4.06 | 4.06 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 1.39 | 1.35 | 1.31 | 1.29 |
Net Worth | 5.45 | 5.41 | 5.37 | 5.35 |
Minority Interest |
Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
---|---|---|---|---|
Revenue | 2.37 | 3.07 | 3.05 | 3.01 |
yoy growth (%) | -22.88 | 0.85 | 1.4 | 14.51 |
Raw materials | -1.23 | -1.27 | -1.15 | -1.06 |
As % of sales | 52.08 | 41.48 | 37.97 | 35.31 |
Employee costs | -0.42 | -0.43 | -0.43 | -0.33 |
Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
---|---|---|---|---|
Profit before tax | 0.03 | 0.25 | 0.12 | 0.1 |
Depreciation | -0.05 | -0.05 | -0.05 | -0.04 |
Tax paid | -0.01 | -0.06 | -0.03 | -0.03 |
Working capital | 0.35 | 0.27 | -0.22 | -0.59 |
Other operating items |
Y/e 31 Mar | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | -22.88 | 0.85 | 1.4 | 14.51 |
Op profit growth | -91.96 | 21.96 | 2.83 | 1.79 |
EBIT growth | -53.42 | 23.04 | -4.42 | 6.8 |
Net profit growth | -89.21 | 100.78 | 26.76 | 52.37 |
Particulars (Rupees in Crores.) | Mar-2021 | Mar-2020 |
---|---|---|
Gross Sales | 2.37 | 3.08 |
Excise Duty | 0 | 0 |
Net Sales | 2.37 | 3.08 |
Other Operating Income | 0 | 0 |
Other Income | 0.25 | 0.17 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
---|---|---|---|---|---|---|---|
Sun Pharmaceuticals Industries Ltd SUNPHARMA | 1,823.35 | 157.3 | 4,37,806.65 | 237.82 | 0.74 | 4,409.74 | 98.75 |
Divis Laboratories Ltd DIVISLAB | 5,140.8 | 81.93 | 1,36,080.52 | 430 | 0.58 | 2,063 | 507.93 |
Cipla Ltd CIPLA | 1,611.9 | 33.1 | 1,31,478.83 | 1,055.94 | 0.8 | 3,752.25 | 346.4 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,417 | 77.52 | 1,16,513.07 | 469 | 0.81 | 2,394 | 201.77 |
Zydus Lifesciences Ltd ZYDUSLIFE | 1,100.5 | 25.69 | 1,12,205.15 | 1,700.8 | 0.27 | 4,035.4 | 156.19 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Chairman & Non Executive Dir.
SANJAY VYANKATESH KULKARNI
Managing Director & CEO
BHARAT BRIJMOHAN SHARMA
Whole-time Director
SRIJNA SHARMA
Independent Director
SACHIN CHANDRAKANT CHAVAN
Independent Director
CHETAN BHIKHUBHAI PATEL
Tel: -
Website: -
Email: -
Tel: -
Website: -
Email: -
Reports by Ganga Pharmaceuticals Ltd
Summary
Ganga Pharmaceuticals Ltd was incorporated as a Public Limited Company in Aug.94 and promoted by Brij Mohan Sharma. he Company is engaged in the business of manufacturing & trading in Pharmaceuticals & allied products (Ayurveda).In Apr.95, the company took over Ganga pharmaceuticals, a proprietory concern (owned by the same promoter), which was manufacturing and marketing ayurvedic products since the last two decades. The company which manufactures ayurvedic medicines, started commercial production in Apr.95. In Jul.96, it came out with a public issue to part-finance the expansion programme involving setting up of a new manufacturing unit for the manufacture of ayurvedic medicines at Murbad, Maharashtra.The company which commenced exports in Jan.96, has marketing arrangements with parties located in Saudi Arabia, Dubai, Italy, Romania and Russia to market its products in their respective regions.
Read More
The Ganga Pharmaceuticals Ltd shares price on BOMBAY STOCK EXCHANGE (BSE) is ₹19.57 today.
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Ganga Pharmaceuticals Ltd is ₹9.47 Cr. as of 26 Aug ‘24
The PE and PB ratios of Ganga Pharmaceuticals Ltd is 195.7 and 1.34 as of 26 Aug ‘24
The 52-week high/low is the highest and lowest price at which a Ganga Pharmaceuticals Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Ganga Pharmaceuticals Ltd is ₹10 and ₹28.49 as of 26 Aug ‘24
Ganga Pharmaceuticals Ltd's CAGR for 5 Years at 26.67%, 3 Years at 57.59%, 1 Year at 81.20%, 6 Month at -23.82%, 3 Month at -20.67% and 1 Month at -20.67%.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Securities Support WhatsApp Number
+91 9892691696
www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.
Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
Invest wise with Expert advice